From identification of the BTK kinase to effective management of leukemia

por Smith, C I E
Publicado 2017

Targets for Ibrutinib Beyond B Cell Malignancies

por Berglöf, A., Hamasy, A., Meinke, S., Palma, M., Krstic, A., Månsson, R., Kimby, E., Österborg, A., Smith, C. I. E.
Publicado 2015

Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant

por Hamasy, A, Wang, Q, Blomberg, K E M, Mohammad, D K, Yu, L, Vihinen, M, Berglöf, A, Smith, C I E
Publicado 2017

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses

por Stenler, S., Lundin, K. E., Hansen, L., Petkov, S., Mozafari, N., Isaguliants, M., Blomberg, P., Smith, C. I. E., Goldenberg, D. M., Chang, C.-H., Ljungberg, K., Hinkula, J., Wahren, B.
Publicado 2017